Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Telmisartan 80 mg vs Valsartan 160 mg on Insulin Sensitivity (HOMA) – WITEVA
2006-003473-27Phase 4Active
- Sponsor
- MedQuality
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of telmisartan and valsartan in hypertension (HTN) (2 arms), sponsored by MedQuality. Primary endpoint: HOMA-index change from baseline to 12 weeks. Started Oct 2006; status: active.
02
Drugs
telmisartanvalsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2006-003473-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003473-27.